NK cells with bispecific antibody show activity against lymphoma cells

The pressure is on for Australia to accept that the coronavirus spreads in the air
13 May 2021
Eating more fruit and vegetables linked to less stress: study
13 May 2021

NK cells with bispecific antibody show activity against lymphoma cells

Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.

Comments are closed.